Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Thomas Cate

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Disorders

Human Influenza

Living Beings

Concepts & Ideas

Immunologic Dose-Response Relationship

Procedures

Phenomena

Anatomy

Nasal Mucosa

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
31
Couch, Robert
17
Keitel, Wendy
11
Atmar, Robert
4
Greenberg, Stephen
3
Ruben, Fred
3
Mbawuike, Innocent
2
Levine, Myron
2
Murphy, Brian
2
El Sahly, Hana
2
Frangogiannis, Nikolaos
1
Glezen, Paul
1
Katz, Jacqueline
1
Belshe, Robert
1
Brady, Rebecca
1
Cox, Manon

Sign-in to see all Coauthors

Publications

TOP 3
Couch Robert B; Atmar Robert L; Cate Thomas R; Quarles John M; Keitel Wendy A; Arden Nancy H; Wells Janet; Niño Diane; Wyde Philip R
Contrasting effects of type I interferon as a mucosal adjuvant for influenza vaccine in mice and humans.
El Sahly H M; Atmar R L; Patel S M; Wells J M; Cate T; Ho M; Guo K; Pasetti M F; Lewis D E; Sztein M B; Keitel W A
Safety, reactogenicity and immunogenicity of Francisella tularensis live vaccine strain in humans.
Keitel Wendy A; Atmar Robert L; Nino Diane; Cate Thomas R; Couch Robert B
Increasing doses of an inactivated influenza A/H1N1 vaccine induce increasing levels of cross-reacting antibody to subsequent, antigenically different, variants.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Thomas Cate (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Couch Robert B; Atmar Robert L; Cate Thomas R; Quarles John M; Keitel Wendy A; Arden Nancy H; Wells Janet; Niño Diane; Wyde Philip R
Contrasting effects of type I interferon as a mucosal adjuvant for influenza vaccine in mice and humans.
Vaccine 2009;27(39):5344-8.
2009: El Sahly H M; Atmar R L; Patel S M; Wells J M; Cate T; Ho M; Guo K; Pasetti M F; Lewis D E; Sztein M B; Keitel W A
Safety, reactogenicity and immunogenicity of Francisella tularensis live vaccine strain in humans.
Vaccine 2009;27(36):4905-11.
2008: Keitel Wendy A; Atmar Robert L; Nino Diane; Cate Thomas R; Couch Robert B
Increasing doses of an inactivated influenza A/H1N1 vaccine induce increasing levels of cross-reacting antibody to subsequent, antigenically different, variants.
The Journal of infectious diseases 2008;198(7):1016-8.
2007: Couch Robert B; Winokur Patricia; Brady Rebecca; Belshe Robert; Chen Wilbur H; Cate Thomas R; Sigurdardottir Bryndis; Hoeper Amy; Graham Irene L; Edelman Robert; He Fenhua; Nino Diane; Capellan Jose; Ruben Frederick L
Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjects.
Vaccine 2007;25(44):7656-63.
2007: Atmar Robert L; Keitel Wendy A; Cate Thomas R; Munoz Flor M; Ruben Fred; Couch Robert B
A dose-response evaluation of inactivated influenza vaccine given intranasally and intramuscularly to healthy young adults.
Vaccine 2007;25(29):5367-73.
2006: Atmar Robert L; Keitel Wendy A; Patel Shital M; Katz Jacqueline M; She Dewei; El Sahly Hana; Pompey Justine; Cate Thomas R; Couch Robert B
Safety and immunogenicity of nonadjuvanted and MF59-adjuvanted influenza A/H9N2 vaccine preparations.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006;43(9):1135-42.
2006: Keitel Wendy A; Atmar Robert L; Cate Thomas R; Petersen Nancy J; Greenberg Stephen B; Ruben Fred; Couch Robert B
Safety of high doses of influenza vaccine and effect on antibody responses in elderly persons.
Archives of internal medicine 2006;166(10):1121-7.
2006: Treanor John J; Schiff Gilbert M; Couch Robert B; Cate Thomas R; Brady Rebecca C; Hay C Mhorag; Wolff Mark; She Dewei; Cox Manon M J
Dose-related safety and immunogenicity of a trivalent baculovirus-expressed influenza-virus hemagglutinin vaccine in elderly adults.
The Journal of infectious diseases 2006;193(9):1223-8.
2001: Keitel W A; Cate T R; Nino D; Huggins L L; Six H R; Quarles J M; Couch R B
Immunization against influenza: comparison of various topical and parenteral regimens containing inactivated and/or live attenuated vaccines in healthy adults.
The Journal of infectious diseases 2001;183(2):329-332.
1998: Frangogiannis N G; Cate T R
Endocarditis and Ureaplasma urealyticum osteomyelitis in a hypogammaglobulinemic patient. A case report and review of the literature.
The Journal of infection 1998;37(2):181-4.
1998: Cate T R
Impact of influenza and other community-acquired viruses.
Seminars in respiratory infections 1998;13(1):17-23.
1997: White A C; Atmar R L; Wilson J; Cate T R; Stager C E; Greenberg S B
Effects of requiring prior authorization for selected antimicrobials: expenditures, susceptibilities, and clinical outcomes.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1997;25(2):230-9.
1997: Couch R B; Keitel W A; Cate T R
Improvement of inactivated influenza virus vaccines.
The Journal of infectious diseases 1997;176 Suppl 1():S38-44.
1997: Keitel W A; Cate T R; Couch R B; Huggins L L; Hess K R
Efficacy of repeated annual immunization with inactivated influenza virus vaccines over a five year period.
Vaccine 1997;15(10):1114-22.
1996: Mbawuike I N; Piedra P A; Cate T R; Couch R B
Cytotoxic T lymphocyte responses of infants after natural infection or immunization with live cold-recombinant or inactivated influenza A virus vaccine.
Journal of medical virology 1996;50(2):105-11.
1996: Frangogiannis N G; Boridy I; Mazhar M; Mathews R; Gangopadhyay S; Cate T
Cyclophosphamide in the treatment of toxic epidermal necrolysis.
Southern medical journal 1996;89(10):1001-3.
1996: Keitel W A; Cate T R; Atmar R L; Turner C S; Nino D; Dukes C M; Six H R; Couch R B
Increasing doses of purified influenza virus hemagglutinin and subvirion vaccines enhance antibody responses in the elderly.
Clinical and diagnostic laboratory immunology 1996;3(5):507-10.
1996: White A C; Atmar R L; Cate T R; Greenberg S R
Enforcing antimicrobial restrictions.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 1996;53(7):796-7.
1995: Kilbourne E D; Couch R B; Kasel J A; Keitel W A; Cate T R; Quarles J H; Grajower B; Pokorny B A; Johansson B E
Purified influenza A virus N2 neuraminidase vaccine is immunogenic and non-toxic in humans.
Vaccine 1995;13(18):1799-803.
1995: Atmar R L; Keitel W A; Cate T R; Quarles J M; Couch R B
Comparison of trivalent cold-adapted recombinant (CR) influenza virus vaccine with monovalent CR vaccines in healthy unselected adults.
The Journal of infectious diseases 1995;172(1):253-7.
1995: Frangogiannis N G; Gangopadhyay S; Cate T
Pemphigus of the larynx and esophagus.
Annals of internal medicine 1995;122(10):803-4.
1994: Mbawuike I N; Dillion S B; Demuth S G; Jones C S; Cate T R; Couch R B
Influenza A subtype cross-protection after immunization of outbred mice with a purified chimeric NS1/HA2 influenza virus protein.
Vaccine 1994;12(14):1340-8.
1994: Keitel W A; Couch R B; Cate T R; Hess K R; Baxter B; Quarles J M; Atmar R L; Six H R
High doses of purified influenza A virus hemagglutinin significantly augment serum and nasal secretion antibody responses in healthy young adults.
Journal of clinical microbiology 1994;32(10):2468-73.
1994: Keitel W A; Couch R B; Cate T R; Maassab H F
Variability in infectivity of cold-adapted recombinant influenza virus vaccines in humans.
The Journal of infectious diseases 1994;169(2):477.
1993: Keitel W A; Couch R B; Quarles J M; Cate T R; Baxter B; Maassab H F
Trivalent attenuated cold-adapted influenza virus vaccine: reduced viral shedding and serum antibody responses in susceptible adults.
The Journal of infectious diseases 1993;167(2):305-11.
1990: Mbawuike I N; Six H R; Cate T R; Couch R B
Vaccination with inactivated influenza A virus during pregnancy protects neonatal mice against lethal challenge by influenza A viruses representing three subtypes.
Journal of virology 1990;64(3):1370-4.
1990: Keitel W A; Couch R B; Cate T R; Six H R; Baxter B D
Cold recombinant influenza B/Texas/1/84 vaccine virus (CRB 87): attenuation, immunogenicity, and efficacy against homotypic challenge.
The Journal of infectious diseases 1990;161(1):22-6.
1989: Cate T R
Prevention of severe lower respiratory tract infections.
Seminars in respiratory infections 1989;4(4):243-4.
1988: Keitel W A; Cate T R; Couch R B
Efficacy of sequential annual vaccination with inactivated influenza virus vaccine.
American journal of epidemiology 1988;127(2):353-64.
1986: Couch R B; Kasel J A; Glezen W P; Cate T R; Six H R; Taber L H; Frank A L; Greenberg S B; Zahradnik J M; Keitel W A
Influenza: its control in persons and populations.
The Journal of infectious diseases 1986;153(3):431-40.
1983: Couch R B; Cate T R
Managing influenza in older patients.
Geriatrics 1983;38(9):61-3, 67, 71-4.
1983: Cate T R; Couch R B; Parker D; Baxter B
Reactogenicity, immunogenicity, and antibody persistence in adults given inactivated influenza virus vaccines - 1978.
Reviews of infectious diseases 1983;5(4):737-47.
1983: Zahradnik J M; Kasel J A; Martin R R; Six H R; Cate T R
Immune responses in serum and respiratory secretions following vaccination with a live cold-recombinant (CR35) and inactivated A/USSR/77 (H1N1) influenza virus vaccine.
Journal of medical virology 1983;11(4):277-85.
1982: Cate T R; Couch R B
Live influenza A/Victoria/75 (H3N2) virus vaccines: reactogenicity, immunogenicity, and protection against wild-type virus challenge.
Infection and immunity 1982;38(1):141-6.
1982: Six H R; Kasel J A; Cate T R
Characterization of human serum strain-specific antihemagglutinin antibody to A/Port Chalmers/73 (H3N2) influenza virus by radioimmunoprecipitation assays.
Journal of clinical microbiology 1982;15(1):87-92.
1981: Anderson P; Insel R A; Smith D H; Cate T R; Couch R B; Glezen W P
A polysaccharide-protein complex from Haemophilus influenzae type b. III. Vaccine trial in human adults.
The Journal of infectious diseases 1981;144(6):530-8.
1981: Quarles J M; Couch R B; Cate T R; Goswick C B
Comparison of amantadine and rimantadine for prevention of type A (Russian) influenza.
Antiviral research 1981;1(3):149-55.
1981: Cate T R; Couch R B
Lack of effect of influenza virus infection on induction and expression of delayed hypersensitivity.
The Journal of infectious diseases 1981;144(3):280.
1981: Martin R R; Couch R B; Greenberg S B; Cate T R; Warr G A
Effects of infection with influenza virus on the function of polymorphonuclear leukocytes.
The Journal of infectious diseases 1981;144(3):279-80.
1980: Murphy B R; Rennels M B; Douglas R G; Betts R F; Couch R B; Cate T R; Chanock R M; Kendal A P; Maassab H F; Suwanagool S; Sotman S B; Cisneros L A; Anthony W C; Nalin D R; Levine M M
Evaluation of influenza A/Hong Kong/123/77 (H1N1) ts-1A2 and cold-adapted recombinant viruses in seronegative adult volunteers.
Infection and immunity 1980;29(2):348-55.
1980: Murphy B R; Markoff L J; Chanock R M; Spring S B; Maassab H F; Kendal A P; Cox N J; Levine M M; Douglas R G; Betts R F; Couch R B; Cate T R
Genetic approaches to attenuation of influenza A viruses for man.
Philosophical transactions of the Royal Society of London. Series B, Biological sciences 1980;288(1029):401-15.

Sign-in to see more